EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy

Sabine Schneider iD, Whitley W Aamodt iD, Amy A Pruitt, Joseph R Berger

Movement Disorders Clinical Practice · 2024-12 · 11 (12) · 1625-1628

DOI: 10.1002/mdc3.14239 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 21.10.2024. Verfasst von Sabine Schneider und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

B‐cell maturation antigen (BCMA)chimeric antigen receptor T‐cell (CAR‐T)movement and neurocognitive treatment‐emergent adverse events (MNT)multiple myelomaparkinsonism

Autor:innen und Institutionen

  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Sabine Schneider, Whitley W Aamodt

Zitieren

APA

Schneider, S., Aamodt, W. W., Pruitt, A. A., & Berger, J. R. (2024). Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy. Movement Disorders Clinical Practice, 11(12), 1625-1628. https://doi.org/10.1002/mdc3.14239

Vancouver

Schneider S, Aamodt WW, Pruitt AA, Berger JR. Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy. Movement Disorders Clinical Practice. 2024;11(12):1625-1628. doi:10.1002/mdc3.14239

BibTeX
@article{Schneider2024,
  author = {Schneider, Sabine and Aamodt, Whitley W and Pruitt, Amy A and Berger, Joseph R},
  title = {Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy},
  journal = {Movement Disorders Clinical Practice},
  year = {2024},
  volume = {11},
  number = {12},
  pages = {1625--1628},
  doi = {10.1002/mdc3.14239}
}
Kostenlos starten →